Literature DB >> 11205730

Protein spray-freeze drying. Effect of atomization conditions on particle size and stability.

H R Costantino1, L Firouzabadian, K Hogeland, C Wu, C Beganski, K G Carrasquillo, M Córdova, K Griebenow, S E Zale, M A Tracy.   

Abstract

PURPOSE: To investigate the effect of atomization conditions on particle size and stability of spray-freeze dried protein.
METHODS: Atomization variables were explored for excipient-free (no zinc added) and zinc-complexed bovine serum albumin (BSA). Particle size was measured by laser diffraction light scattering following sonication in organic solvent containing poly(lactide-co-glycolide) (PLG). Powder surface area was determined from the N2 vapor sorption isotherm. Size-exclusion chromatography (SEC) was used to assess decrease in percent protein monomer. Fourier-transform infrared (FTIR) spectroscopy was employed to estimate protein secondary structure. PLG microspheres were made using a non-aqueous, cryogenic process and release of spray-freeze dried BSA was assessed in vitro.
RESULTS: The most significant atomization parameter affecting particle size was the mass flow ratio (mass of atomization N2 relative to that for liquid feed). Particle size was inversely related to specific surface area and the amount of protein aggregates formed. Zinc-complexation reduced the specific surface area and stabilized the protein against aggregation. FTIR data indicated perturbations in secondary structure upon spray-freeze drying for both excipient-free and zinc-complexed protein.
CONCLUSIONS: Upon sonication, spray-freeze dried protein powders exhibited friability, or susceptibility towards disintegration. For excipient-free protein, conditions where the mass flow ratio was > -0.3 yielded sub-micron powders with relatively large specific surface areas. Reduced particle size was also linked to a decrease in the percentage of protein monomer upon drying. This effect was ameliorated by zinc-complexation, via a mechanism involving reduction in specific surface area of the powder rather than stabilization of secondary structure. Reduction of protein particle size was beneficial in reducing the initial release (burst) of the protein encapsulated in PLG microspheres.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11205730     DOI: 10.1023/a:1007570030368

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

1.  FTIR characterization of the secondary structure of proteins encapsulated within PLGA microspheres.

Authors:  K Fu; K Griebenow; L Hsieh; A M Klibanov
Journal:  J Control Release       Date:  1999-04-19       Impact factor: 9.776

2.  On the structural preservation of recombinant human growth hormone in a dried film of a synthetic biodegradable polymer.

Authors:  K G Carrasquillo; H R Costantino; R A Cordero; C C Hsu; K Griebenow
Journal:  J Pharm Sci       Date:  1999-02       Impact factor: 3.534

3.  The stabilization and encapsulation of human growth hormone into biodegradable microspheres.

Authors:  O L Johnson; W Jaworowicz; J L Cleland; L Bailey; M Charnis; E Duenas; C Wu; D Shepard; S Magil; T Last; A J Jones; S D Putney
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

4.  Surface-induced denaturation of proteins during freezing and its inhibition by surfactants.

Authors:  B S Chang; B S Kendrick; J F Carpenter
Journal:  J Pharm Sci       Date:  1996-12       Impact factor: 3.534

5.  Proteins in frozen solutions: evidence of ice-induced partial unfolding.

Authors:  G B Strambini; E Gabellieri
Journal:  Biophys J       Date:  1996-02       Impact factor: 4.033

6.  Fourier-transform infrared spectroscopic investigation of protein stability in the lyophilized form.

Authors:  H R Costantino; K Griebenow; P Mishra; R Langer; A M Klibanov
Journal:  Biochim Biophys Acta       Date:  1995-11-15

7.  Physical chemistry of freeze-drying: measurement of sublimation rates for frozen aqueous solutions by a microbalance technique.

Authors:  M J Pikal; S Shah; D Senior; J E Lang
Journal:  J Pharm Sci       Date:  1983-06       Impact factor: 3.534

8.  Surface denaturation at solid-void interface--a possible pathway by which opalescent particulates form during the storage of lyophilized tissue-type plasminogen activator at high temperatures.

Authors:  C C Hsu; H M Nguyen; D A Yeung; D A Brooks; G S Koe; T A Bewley; R Pearlman
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

9.  Separation of freezing- and drying-induced denaturation of lyophilized proteins using stress-specific stabilization. II. Structural studies using infrared spectroscopy.

Authors:  S J Prestrelski; T Arakawa; J F Carpenter
Journal:  Arch Biochem Biophys       Date:  1993-06       Impact factor: 4.013

10.  Separation of freezing- and drying-induced denaturation of lyophilized proteins using stress-specific stabilization. I. Enzyme activity and calorimetric studies.

Authors:  J F Carpenter; S J Prestrelski; T Arakawa
Journal:  Arch Biochem Biophys       Date:  1993-06       Impact factor: 4.013

View more
  39 in total

1.  Improvement of dissolution rates of poorly water soluble APIs using novel spray freezing into liquid technology.

Authors:  Jiahui Hu; True L Rogers; Judith Brown; Tim Young; Keith P Johnston; Robert O Williams
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

2.  Statistical modeling of protein spray drying at the lab scale.

Authors:  Kristin B Prinn; Henry R Costantino; Mark Tracy
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

3.  Protein powders for encapsulation: a comparison of spray-freeze drying and spray drying of darbepoetin alfa.

Authors:  Xichdao C Nguyen; John D Herberger; Paul A Burke
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

4.  Spray-coating for biopharmaceutical powder formulations: beyond the conventional scale and its application.

Authors:  Yuh-Fun Maa; Mahmoud Ameri; Robert Rigney; Lendon G Payne; Dexiang Chen
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

5.  Antibody nanoparticle dispersions formed with mixtures of crowding molecules retain activity and in vivo bioavailability.

Authors:  Maria A Miller; Tarik A Khan; Kevin J Kaczorowski; Brian K Wilson; Aileen K Dinin; Ameya U Borwankar; Miguel A Rodrigues; Thomas M Truskett; Keith P Johnston; Jennifer A Maynard
Journal:  J Pharm Sci       Date:  2012-07-06       Impact factor: 3.534

Review 6.  Particle engineering for pulmonary drug delivery.

Authors:  Albert H L Chow; Henry H Y Tong; Pratibhash Chattopadhyay; Boris Y Shekunov
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

7.  Monitoring ibuprofen release from multiparticulates: in situ fiber-optic technique versus the HPLC method: a technical note.

Authors:  Vishal Bijlani; Domotiere Yuonayel; Sabitha Katpally; Beatrice Nkem Chukwumezie; Moji Christianah Adeyeye
Journal:  AAPS PharmSciTech       Date:  2007-07-06       Impact factor: 3.246

8.  Formation of stable submicron protein particles by thin film freezing.

Authors:  Joshua D Engstrom; Edwina S Lai; Baltej S Ludher; Bo Chen; Thomas E Milner; Robert O Williams; G Barrie Kitto; Keith P Johnston
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

Review 9.  Effects of glycosylation on the stability of protein pharmaceuticals.

Authors:  Ricardo J Solá; Kai Griebenow
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

10.  Formulation of High-Performance Dry Powder Aerosols for Pulmonary Protein Delivery.

Authors:  Erin M Wilson; J Christopher Luft; Joseph M DeSimone
Journal:  Pharm Res       Date:  2018-08-23       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.